Daily Stock Setups

King Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference

Posted on: Fri, 13 Nov 2009 16:00:00 EST

Symbols: KG

Do you know when to trade KG ?

Check for a PowerRating from TradingMarkets

BRISTOL, Tenn., Nov 13, 2009 (BUSINESS WIRE) --
KG | Quote | Chart | News | PowerRating -- King Pharmaceuticals, Inc. (NYSE:KG) today announced plans to present at
the Lazard Capital Markets 6th Annual Healthcare Conference
on Wednesday, November 18, 2009, at 2:15 pm EST, at the St. Regis Hotel
in New York, New York. The presentation may include a discussion of the
Company's marketed products, pipeline, strategy for growth, financial
results and expectations, and other matters relating to its business.

About King Pharmaceuticals, Inc.

King, headquartered in Bristol, Tennessee, is a vertically integrated
branded pharmaceutical company. King, an S&P 500 Index company, seeks to
capitalize on opportunities in the pharmaceutical industry through the
development, including through in-licensing arrangements and
acquisitions, of novel branded prescription pharmaceutical products and
technologies that complement the Company's focus in specialty-driven
markets, particularly neuroscience and hospital. King's wholly-owned
subsidiary, Alpharma, Inc., is also a leader in the development,
registration, manufacture and marketing of pharmaceutical products for
food producing animals.

About Forward-looking Statements

This release contains forward-looking statements which reflect
management's current views of future events and operations, including,
but not limited to, statements pertaining to the Company's presentation
on November 18, 2009. These forward-looking statements involve certain
significant risks and uncertainties, and actual results may differ
materially from the forward-looking statements. King does not undertake
to publicly update or revise any of its forward-looking statements even
if experience or future changes show that the indicated results or
events will not be realized.

SOURCE: King Pharmaceuticals, Inc.


King Pharmaceuticals, Inc. 
Jack Howarth, 908-429-8350 
Vice President, Investor Relations

For full details on King Pharmaceuticals Inc (KG) KG. King Pharmaceuticals Inc (KG) has Short Term PowerRatings at TradingMarkets. Details on King Pharmaceuticals Inc (KG) Short Term PowerRatings is available at This Link.

More News: Market Updates | Stock Alerts | All Trading News

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.